◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
泰林生物 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013
+Revenue 349.0M 270.0M 374.0M 283.0M 200.0M 181.0M 159.0M 142.0M 112.0M 82.3M 59.5M 94.5M
Revenue Growth % 29.3% -27.8% 32.2% 41.5% 10.5% 13.8% 12.0% 26.8% 36.0% 38.4% -37.0% --
Total Revenue 349.0M 270.0M 374.0M 283.0M 200.0M 181.0M 159.0M 142.0M 112.0M 82.3M 59.5M 94.5M
Cost Of Revenue 197.0M 141.0M 177.0M 108.0M 74.4M 76.8M 63.2M 56.3M 46.0M 33.1M 22.9M 37.7M
+Gross Profit 152.0M 129.0M 197.0M 175.0M 125.6M 104.2M 95.8M 85.7M 66.0M 49.2M 36.6M 56.7M
Gross Margin % 43.6% 47.8% 52.7% 61.8% 62.8% 57.6% 60.2% 60.3% 59.0% 59.8% 61.5% 60.1%
Total Operating Cost 350.0M 265.0M 311.0M 227.0M 164.0M 153.0M 119.0M 101.0M 84.9M 70.2M 52.9M 72.4M
Selling Expenses 43.1M 39.2M 42.9M 39.1M 31.1M 25.8M 19.7M 16.9M 14.2M 12.3M 9.5M 11.0M
Admin Expenses 35.3M 31.8M 33.1M 24.8M 23.3M 18.3M 11.8M 10.9M 10.1M 23.8M 19.7M 22.2M
Rd Expenses 62.3M 58.4M 64.5M 55.0M 37.7M 29.3M 21.1M 15.5M 13.5M -- -- --
Finance Expenses 5.0M -10.8M -8.9M -6.6M -6.6M -306,100 -470,100 -1.3M -1.0M -121,500 -87,800 -101,100
+Operating Income 12.4M 21.8M 79.6M 69.8M 51.9M 38.3M 53.6M 46.9M 26.9M 12.6M 7.0M 22.1M
Operating Margin % 3.6% 8.1% 21.3% 24.7% 26.0% 21.2% 33.7% 33.0% 24.1% 15.3% 11.8% 23.4%
Non Operating Income 1.1M 769,100 1.4M 61,400 80,200 232,000 164,600 4.9M 6.2M 5.0M 4.6M 2.3M
Non Operating Expenses 774,400 571,700 1.1M 210,900 283,500 20,500 86,000 7,400 64,200 128,700 75,700 107,400
Investment Income 1.9M -11,700 360,700 2.4M -- -- -- -- 51,800 384,200 360,500 --
Fair Value Change Income -- -- -- 47,900 -- -- -- -- -- -- -- --
Asset Disposal Income -- -2,200 24,100 -- -9,400 -11,600 22,800 -- -- -- -- --
Asset Impairment Loss 699,400 122,700 662,200 896,900 81,000 4,000 1.2M 745,600 128,900 284,600 -72,900 334,300
Other Income 11.9M 17.4M 16.7M 11.1M 15.9M 9.9M 13.4M 6.0M -- -- -- --
Income Before Tax 12.8M 22.0M 79.9M 69.6M 51.7M 38.5M 53.7M 51.7M 33.1M 17.5M 11.6M 24.3M
Income Tax 512,900 3.5M 261,100 6.1M 3.3M 4.1M 5.5M 6.7M 4.1M 2.1M 1.4M 2.9M
+Net Income 12.3M 18.4M 79.7M 63.5M 48.4M 34.4M 48.2M 45.0M 29.0M 15.4M 10.1M 21.5M
Net Margin % 3.5% 6.8% 21.3% 22.4% 24.2% 19.0% 30.3% 31.7% 25.9% 18.7% 17.0% 22.7%
Net Income Attributable 13.1M 19.7M 79.7M 63.5M 48.4M 34.4M 48.2M 45.0M 29.0M 15.4M 10.1M 21.5M
Minority Interest -797,000 -1.2M -- -- -- -- -- -- -- -- -- --
Eps Basic 0.12 0.18 0.74 0.76 0.95 0.88 1.24 1.15 0.74 0.43 1.00 2.12
Eps Diluted 0.12 0.17 0.71 0.76 0.95 0.88 1.24 1.15 0.74 0.43 -- --
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013
Cash And Equivalents 265.0M 397.0M 577.0M 302.0M 322.0M 51.9M 44.4M 67.0M 66.0M 21.0M 8.0M 14.9M
Trading Financial Assets -- -- -- 20.0M -- -- -- -- -- -- -- --
Accounts Receivable 43.5M 36.1M 42.6M 38.5M 17.9M 32.9M 31.0M 20.4M 11.9M 9.7M 5.7M 8.9M
Notes Receivable -- -- -- 270,000 -- 206,100 7.8M 3.6M 3.1M 4.1M 3.1M 3.7M
Notes And Accounts Receivable 43.5M 36.1M 42.6M 38.8M 17.9M 33.1M 38.8M 24.0M 15.0M 13.7M 8.8M 12.5M
Prepayments 3.8M 4.6M 6.8M 8.6M 7.5M 5.4M 4.0M 2.6M 2.2M 2.0M 625,200 981,500
Inventory 144.0M 161.0M 111.0M 122.0M 63.2M 42.3M 46.4M 30.5M 30.3M 25.8M 17.5M 21.1M
Total Current Assets 633.0M 639.0M 764.0M 514.0M 426.0M 150.0M 142.0M 132.0M 115.0M 101.0M 47.3M 49.7M
Long Term Equity Investment 8.1M 4.0M -- -- -- -- -- -- -- -- -- --
Fixed Assets -- 265.0M 103.0M 95.9M 85.3M 88.5M 88.2M -- -- 21.8M 21.1M 25.0M
Fixed Assets Total 260.0M 265.0M 103.0M 95.9M 85.3M 88.5M 88.2M 19.5M 19.5M 21.8M 21.1M 25.0M
Construction In Progress -- 4.3M 15.9M 657,800 994,700 528,400 -- 24.7M 1.5M -- -- --
Construction In Progress Total 6.7M 4.3M 15.9M 657,800 994,700 528,400 -- 24.7M 1.5M -- -- --
Intangible Assets 10.9M 11.3M 11.8M 12.4M 11.6M 11.9M 12.1M 12.4M 12.8M 2.3M 2.4M 2.6M
Long Term Deferred Expenses 31.2M 31.8M 13.0M 8.5M 3.1M 3.2M 3.5M 4.0M 4.6M 4.6M 5.1M 4.7M
Total Non Current Assets 327.0M 335.0M 159.0M 141.0M 114.0M 116.0M 113.0M 62.0M 40.7M 30.0M 31.1M 32.3M
Total Assets 960.0M 974.0M 923.0M 656.0M 540.0M 267.0M 255.0M 194.0M 156.0M 131.0M 78.4M 82.0M
Short Term Borrowings 3.7M -- -- -- -- -- -- 19.5M -- -- -- --
Accounts Payable 15.2M 14.6M 12.7M 14.5M 11.2M 12.2M 9.5M 8.6M 6.0M 8.0M 2.0M 3.6M
Advance Receipts -- -- -- -- -- 13.5M 17.6M 5.3M 18.7M 15.7M 6.7M 3.9M
Contract Liabilities 76.6M 94.4M 72.0M 91.6M 44.7M -- -- -- -- -- -- --
Total Current Liabilities 136.0M 162.0M 129.0M 153.0M 95.3M 37.8M 60.4M 46.2M 39.2M 33.8M 23.4M 17.1M
Total Non Current Liabilities 3.4M 161.0M 146.0M 5.0M 498,600 -- -- 951,900 441,900 -- -- --
Total Liabilities 139.0M 323.0M 275.0M 158.0M 95.7M 37.8M 60.4M 47.1M 39.7M 33.8M 23.4M 17.1M
Paid In Capital 121.0M 109.0M 83.2M 52.0M 52.0M 39.0M 39.0M 39.0M 39.0M 39.0M 10.1M 10.1M
Capital Reserve 421.0M 194.0M 213.0M 228.0M 228.0M 43.1M 43.1M 43.1M 43.1M 43.1M -- --
Surplus Reserve 27.6M 27.6M 27.5M 21.3M 20.3M 17.0M 13.5M 9.0M 4.5M 1.5M 5.6M 5.6M
Retained Earnings 251.0M 249.0M 254.0M 196.0M 144.0M 130.0M 99.2M 55.4M 29.8M 13.8M 39.4M 49.2M
Minority Equity 679,200 1.5M -- -- -- -- -- -- -- -- -- --
Equity Attributable 820.0M 649.0M 647.0M 497.0M 444.0M 229.0M 195.0M 146.0M 116.0M 97.4M 55.0M 64.9M
Total Equity 821.0M 650.0M 647.0M 497.0M 444.0M 229.0M 195.0M 146.0M 116.0M 97.4M 55.0M 64.9M
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013
Cash From Sales 332.0M 313.0M 375.0M 327.0M 266.0M 176.0M 161.0M 126.0M 113.0M 90.2M 70.8M 84.1M
Tax Refunds Received 10.3M 10.1M 13.1M 9.1M 9.0M 4.9M 5.6M 6.0M 5.1M 2.3M 2.3M 1.8M
Total Operating Cash Inflow 356.0M 348.0M 408.0M 363.0M 296.0M 193.0M 179.0M 138.0M 128.0M 96.3M 76.1M 87.4M
Cash Paid For Goods 124.0M 148.0M 126.0M 153.0M 83.7M 59.6M 56.6M 38.7M 27.8M 23.1M 13.1M 26.7M
Cash Paid To Employees 146.0M 138.0M 133.0M 103.0M 65.6M 58.0M 45.7M 37.0M 31.6M 26.3M 25.6M 24.3M
Taxes Paid 27.3M 24.4M 30.6M 29.7M 13.8M 18.2M 19.4M 22.1M 19.1M 9.4M 10.5M 11.4M
Total Operating Cash Outflow 331.0M 346.0M 318.0M 327.0M 189.0M 164.0M 141.0M 115.0M 96.2M 71.8M 58.6M 75.9M
Operating Cash Flow 24.7M 1.9M 89.4M 36.0M 106.0M 29.0M 37.3M 23.0M 31.6M 24.5M 17.5M 11.5M
Total Investing Cash Inflow 708.0M 398.0M 285.0M 361.0M 515.0M 178.0M 216.0M 60.3M 38.1M 593,000 360,500 --
Total Investing Cash Outflow 751.0M 570.0M 449.0M 530.0M 483.0M 210.0M 262.0M 107.0M 14.2M 28.2M 13.1M 2.3M
Investing Cash Flow -42.4M -172.0M -164.0M -169.0M 32.3M -31.9M -45.9M -46.2M 23.8M -27.6M -12.7M -2.3M
Cash From Borrowings 15.6M 63.0M 256.0M -- -- -- -- 19.5M -- -- 480,000 --
Dividends And Interest Paid 11.0M 27.2M 17.8M 9.8M 31.2M -- 44,300 15.3M 10.1M 8.0M 12.0M --
Debt Repayments 15.1M 63.0M 49.9M -- -- -- 19.5M -- -- -- 480,000 --
Total Financing Cash Inflow 15.6M 76.6M 256.0M -- 213.0M -- 20.1M 19.5M -- 23.9M 480,000 --
Total Financing Cash Outflow 26.1M 90.2M 71.9M 13.7M 47.3M -- 19.5M 35.3M 10.1M 8.0M 12.5M --
Financing Cash Flow -10.5M -13.6M 184.0M -13.7M 166.0M -- 521,800 -15.8M -10.1M 15.9M -12.0M --
Net Change In Cash -28.1M -184.0M 109.0M -147.0M 304.0M -3.0M -8.1M -39.0M 45.3M 12.8M -7.2M 9.2M
Ending Cash Balance 69.9M 97.9M 282.0M 173.0M 320.0M 15.7M 18.7M 26.8M 65.8M 20.5M 7.7M 14.9M
Capex 18.5M 176.0M 29.1M 25.9M 7.1M 22.4M 42.3M 26.5M 14.2M 2.2M 1.1M 2.3M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...